Literature DB >> 24648819

Psychiatric neural networks and neuropharmacology: Selected advances and novel implications.

Abdelaziz Ghanemi1.   

Abstract

Psychiatric disorders are often considered as simple imbalances between a limited number of cerebral neurotransmitters. In fact, it is more complicated than this "simple approach" and each psychiatric disorder constitutes network dysfunction within which several agents and factors are implicated. Thus, the therapeutical perspectives and implications are as vast and as numerous as the diversity of those network dysfunctions. Furthermore, the description of factors influencing diseases prognoses and treatment efficacy indicates new elements to consider both in therapies and drug researches.

Entities:  

Keywords:  Neural networks; Potential target; Psychiatry; Therapeutical implication

Year:  2013        PMID: 24648819      PMCID: PMC3950528          DOI: 10.1016/j.jsps.2013.01.008

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  90 in total

Review 1.  Trajectories of brain development: point of vulnerability or window of opportunity?

Authors:  Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

2.  Treating major depression in children and adolescents: research is needed into safer and more effective drugs.

Authors:  Macey L Murray; Ian C K Wong; Corinne S de Vries
Journal:  BMJ       Date:  2004-02-28

3.  Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.

Authors:  Christopher P Ford; Gregory P Mark; John T Williams
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

4.  Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice.

Authors:  Qian Li; Tian Luo; Xue Jiang; Jing Wang
Journal:  Neuropharmacology       Date:  2011-09-14       Impact factor: 5.250

5.  Rising prevalence of antidepressants among US youths.

Authors:  Julie Magno Zito; Daniel J Safer; Susan DosReis; James F Gardner; Karen Soeken; Myde Boles; Frances Lynch
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

6.  Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).

Authors:  R Bücheler; C H Gleiter; P Schwoerer; I Gaertner
Journal:  Pharmacopsychiatry       Date:  2005-01       Impact factor: 5.788

Review 7.  The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression.

Authors:  Derick E Vergne; Charles B Nemeroff
Journal:  Curr Psychiatry Rep       Date:  2006-12       Impact factor: 5.285

8.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

9.  Buprenorphine treatment of refractory depression.

Authors:  J A Bodkin; G L Zornberg; S E Lukas; J O Cole
Journal:  J Clin Psychopharmacol       Date:  1995-02       Impact factor: 3.153

Review 10.  Safety of selective serotonin reuptake inhibitors in pregnancy.

Authors:  Sura Alwan; Jan M Friedman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

View more
  7 in total

1.  Shorter and sturdier bridges between traditional Chinese medicines and modern pharmacology.

Authors:  Abdelaziz Ghanemi; Besma Boubertakh
Journal:  Saudi Pharm J       Date:  2014-03-07       Impact factor: 4.330

Review 2.  Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2013-08-13       Impact factor: 4.330

3.  Is mapping borders between pharmacology and toxicology a necessity?

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2014-04-02       Impact factor: 4.330

4.  How important is pharmacognosy for doctors and dentists?

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Dent J       Date:  2015-01

5.  Cell cultures in drug development: Applications, challenges and limitations.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2014-04-20       Impact factor: 4.330

Review 6.  Broken Energy Homeostasis and Obesity Pathogenesis: The Surrounding Concepts.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  J Clin Med       Date:  2018-11-20       Impact factor: 4.241

7.  For dentists and doctors: The neglected concepts about the factors influencing the effects of drugs.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Dent J       Date:  2015-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.